Cellular Physiology and Biochemistry · 2013 · 43 citations · 25 references
Taken together, we suggest that BBR may suppress TPA-induced VEGF and FN as well as VEGF-induced FN through the inhibition of the PI-3K/AKT pathway in breast cancer cells. Therefore, we suggest that BBR may be used as a candidate drug for the inhibition of angiogenesis of human breast cancer.
25
Michele Relf, S LeJeune, Prudence A. E. Scott et al. · PubMed · 1997 · 834 citations
Jens Gille · The EMBO Journal · 1997 · 253 citations · Full text
Transcriptional Regulation, Signal Transduction, Developmental Biology +14